Abstract
Indications at present are very strong that we are on the verge of a period of indiscriminate and reckless use of Ehrlich's new remedy, 606, or salvarsan, as it is known commercially, that will result in disappointment in that valuable remedy and—what is more important— in damage to many syphilitic patients, chiefly, let us hope, from neglect of established measures of treatment. Indeed, it will be very fortunate if we do not have another therapeutic fiasco, like that following the announcement of Koch's tuberculin, in which a valuable remedy failed to come up to first expectations, and thereby caused disappointment from which it did not recover for ten years. For in the excitement over 606 we are apparently remembering only that it was introduced to cure syphilis, and are therefore assuming that it will cure it, and are not taking heed of the fact that experience already is showing that
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
